Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation

Improving the therapeutic efficacy of gene therapy for duchenne muscular dystrophy (DMD) by evaluating and managing inflammation

Duchenne muscular dystrophy (DMD): is a rare, life-limiting genetic disorder for which no curative treatment currently exists. While various gene therapy approaches, some approved and others still under clinical investigation have been explored, they have not consistently produced the desired outcom...

Full description

Saved in:
Bibliographic Details
Main Authors: Kadalraja Raghavan, Nobunao Ikewaki, Senthilkumar Preethy, Samuel J. K. Abraham
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Genetics
Subjects:
duchenne muscular dystrophy (DMD)
gene therapy
inflammation
immune reaction
adjuvant
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2025.1569289/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items